PMID: 6850327Apr 18, 1983Paper

The effect of streptomycin on the neuromuscular junction of the frog

Brain Research
M Tamaki

Abstract

The neuromuscular block produced by streptomycin was studied in the frog sartorius muscle by means of intracellular recording and iontophoretic application of acetylcholine. Decreases of the end-plate potentials (e.p.p.s) and acetylcholine potentials (ACh potentials) were observed following the application of streptomycin. At a concentration of 10(-4) M, the e.p.p. was 36.8 +/- 5.5% (mean +/- S.E.) (n = 12), and the ACh potential was 53.7 +/- 3.8% (n = 12) of the control size. The resting membrane potential and membrane conductance of the muscle fibers were not affected by streptomycin. Streptomycin did not significantly alter the spontaneous prejunctional activity, but the amplitude of the miniature end-plate potentials (m.e.p.p.s) was decreased. After the application of higher concentrations of streptomycin, the quantum content decreased from the control value. It is suggested that the reduction of the e.p.p. amplitude produced by streptomycin is mainly due to a decrease in the sensitivity of the end-plate membrane. In addition, at higher concentrations, streptomycin reduced the amount of transmitter released from the motor nerve in response to a nerve volley.

References

May 1, 1970·Anesthesia and Analgesia·C B PittingerR Adamson
Apr 1, 1973·European Journal of Pharmacology·K L DretchenJ P Long
Apr 1, 1967·The Journal of Physiology·B Katz, R Miledi
Jun 28, 1954·The Journal of Physiology·J DEL CASTILLO, B KATZ
Apr 27, 1956·The Journal of Physiology·I A BOYD, A R MARTIN
Dec 1, 1960·British Journal of Pharmacology and Chemotherapy·M N JINDAL, V R DESHPANDE
Feb 1, 1962·Acta Physiologica Scandinavica·D ELMQVIST, J O JOSEFSSON
Jul 1, 1963·The Journal of Physiology·J G BLACKMANC RAY
Nov 2, 1963·British Medical Journal·E D ROSSA B TELFER

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.